Ardiabetes Logo
Menu

Publications

  1. Kalyanaraman K, Snehalatha C, Arjundas G, Gajanan N, Ramamurthi B. Maple syrup urine Disease (Branched-Chain Keto-aciduria) Variant type manifesting as hyperkinetic behaviour and mental retardation. Report of two cases. J Neurological of Sciences. 1972 15: 209 – 217.
  2. Snehalatha C, Valmikinathan K, Srinivas K, Jagannathan. Creatinine phosphokinase level in neuromulscular disorders effect of dilution and dialysis. Clinica Chimica Acta. 1973 Sep; 44: 229 – 235.
  3. Valmikinathan K, Mascreen M, Meenakshisundaram E, Snehalatha C. Biochemical aspects of motor neurone disease–Madras pattern. J Neurol Neurosurg Psychiatry. 1973 Oct;36:753-6. PMID: 4753872
  4. Snehalatha C, Mascreen K, Valmikinatha K, Jagannathan K. Dialysis effect on serum creatinine phosphokinase during steroid therapy in deermatomyositis. Clinica Chimica Acta. 1974 Jan; 53: 217 – 220.
  5. Snehalatha C, Valmikinathan K. Creatinine phosphokinase level in limb girdle muscular dystrophy: Effect of Dialysis. Clinica chimica Acta. 1974 Sep; 51:315 – 318.
  6. J. Oya, D. Vistisen, D. L. Christensen, D. Faurholt-Jepsen, V. Mohan, A. Ramachandran, S. K. H. Chew, J. E. Shaw and M. M. E. Jørgensen. Geographic differences in the associations between impaired glucose regulation and cardiovascular risk factors among young adults. Diabetic Medicine 2015; 32: 497-504
  7. Michalina Błażkiewicz, Lakshmi Sundar, Aoife Healy, Ambady Ramachandran, Nachiappan Chockalingam, Roozbeh Naemi. Assessment of lower leg muscle force distribution during isometric ankle dorsi and plantar flexion in patients with diabetes: a preliminary study. Journal of Diabetes and Its Complications 2015; 29:282-287(Foot)
  8. Jagannathan Ram, Chamukuttan Snehalatha,Sundaram Selvam ,Arun Nanditha ,Ananth Samith Shetty, Ian F. Godsland, Desmond G. Johnston, Ambady Ramachandran. The oral disposition index is a strong predictor of incident diabetes in Asian Indian prediabetic men Acta Diabetol. 2015; 52: 733-741(IDPP3-7)
  9. Ram J, Snehalatha C, Selvam S, Nanditha A, Samith A Shetty, Arun R, Godsland IF, Johnston DG, Ramachandran A. Retinol Binding Protein – 4 Predicts Incident Diabetes in Asian Indian Men with Prediabetes. BioFactors 2015; 41:160-165 (IDPP3-8)
  10. Vinitha R, Ram J, Snehalatha C, Nanditha A, Samith A Shetty, Arun R, Godsland IF, Johnston DG, Ramachandran A. Adiponectin, Leptin, Interleukin-6 and HbA1c in the Prediction of Incident Type 2 Diabetes: A Nested Case-Control Study in Asian Indian Men with Impaired Glucose Tolerance, Diabetes Res Clin Pract. 2015; 109: 340-346 (IDPP3-9)
  11. Ramachandran A, Venkatraman S, Moses A, Vijayakumar J. Hyp-O-besity: Unmet Challenge in Management of Type 2 Diabetes Mellitus and Cardiovascular Risk. Diabetes Metab 2015, 6:4 http://dx.doi.org/10.4172/2155-6156.1000520
  12. Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331 288 participants NCD Risk Factor Collaboration (NCD-RisC) Lancet Diabetes Endocrinol 2015; 3: 624–37
  13. Tamara Brown, Sarah Smith, Raj Bhopal, Adetayo Kasim and Carolyn Summerbell. Diet and Physical Activity Interventions to Prevent or Treat Obesity in South Asian Children and Adults: A Systematic Review and Meta-Analysis Int. J. Environ. Res. Public Health 2015, 12, 566-594 (only acknowledgement)
  14. A. Ramachandran. Current guidelines for treatment of type II diabetes: Are we pushing the limits of the evidence base? Article: Journal of Indian College of Cardiology 5 2015, 21-27
  15. Susairaj Priscilla, Arun Nanditha, Mary Simon, Krishnamoorthy Satheesh, Sathish Kumar, Ananth Samith Shetty, Chamukuttan Snehalatha, Desmond G. Johnston, Ian F. Godsland, Nicholas J. Wareham, Ambady Ramachandran. A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India—Outcome of screening. Diabetes Res Clin Pract. 2015 Dec;110(3):335-40. (IDPP-5)
  16. Nanditha A, Ma RC, Ramachandran A, Snehalatha C, Chan JC, Chia KS, Shaw JE, Zimmet PZ. Diabetes in Asia and the Pacific: Implications for the Global Epidemic.Diabetes Care. 2016;39(3):472-85.
  17. Holman RR, Bethel MA, George J, Sourij H, Doran Z, Keenan J, Khurmi NS, Mentz RJ, Oulhaj A, Buse JB, Chan JC, Iqbal N, Kundu S, Maggioni AP, Marso SP, Öhman P, Pencina MJ, Poulter N, Porter LE, Ramachandran A, Zinman B, Hernandez AF. Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial.Am Heart J. 2016;174:103-10 (EXSCEL-1)
  18. Juliana C N Chan, Edward W Gregg, Jennifer Sargent, Richard Horton Reducing global diabetes burden by implementing solutions and identifying gaps: a Lancet Commission Lancet 2016; 387: No. 10027, p1494–1495
  19. Khunti K, Alsifri S, Aronson R, Berković MC, Enters-Weijnen C, Forsén T, Galstyan G, Geelhoed-Duijvestijn P, Goldfracht M, Gydesen H, Kapur R, Lalic N, Ludvik B, Moberg E, Pedersen-Bjergaard U, Ramachandran A; HAT Investigator Group. Rates and predictors of hypoglycaemia in 27,585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obes Metab. 2016 Sep;18(9):907-15. (HAT-1)
  20. Chamukuttan S, Ram J, Nanditha A, Shetty AS, Sevick MA, Bergman M, Johnston DG, Ramachandran A. Baseline Level of 30 Minutes Plasma Glucose is an Independent Predictor of Incident Diabetes Among Asian Indians: Analysis of Two Diabetes Prevention Programmes.Diabetes Metab Res Rev. 2016 Mar 16. 32(7):762-767 (IDPP-1 & 3)
  21. William T. Cefalu, John B. Buse,Jaakko Tuomilehto,G. Alexander Fleming,4 Ele Ferrannini,Hertzel C. Gerstein,Peter H. Bennett,Ambady Ramachandran, Itamar Raz,Julio Rosenstock, and Steven E. Kahn. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum Diabetes Care 2016;39:1186–1201
  22. NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387(10026):1377-96.
  23. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.Lancet. 2016 Apr 9;387(10027):1513-30
  24. Naemi R, Chatzistergos P, Sundar L, Chockalingam N, Ramachandran A. Differences in the mechanical characteristics of plantar soft tissue between ulcerated and non-ulcerated foot.J Diabetes Complications. 2016; pii: S1056-8727(16)30183-0. (Foot)
  25. NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017 Jan 7;389(10064):37-55
  26. Arun Raghavan, Nanditha Arun, Snehalatha Chamukuttan, Priscilla Susairaj, Vijaya Lakshminarayanan and Ramachandran Ambady(IDPP-1 & 2) Metabolic Profile of Persons with Newly Diagnosed Diabetes Using either Glycoslated Haemoglobin or Oral Glucose Tolerance Test in Primary Prevention Trials in Asian Indians. J Metabolic Synd 2016, 5:3
  27. NCD Risk Factor Collaboration (NCD-RisC) A century of trends in adult human height. Elife. 2016 Jul 26;5.
  28. William T. Cefalu, John B. Buse,Jaakko Tuomilehto,G. Alexander Fleming,Ele Ferrannini,Hertzel C. Gerstein,Peter H. Bennett, Ambady Ramachandran,Itamar Raz, Julio Rosenstock and Steven E. Kahn. Response to comment on Cefalu et al.Update and Next Steps for Real-WorldTranslation of Interventions for Type 2 Diabetes Prevention: Reflections from a Diabetes Care Editors’ Expert Forum. Diabetes Care 2016; 39:1186–1201 Diabetes Care 2017; 40:e23–e24 | DOI: 10.2337/dci16-0036
  29. Sundaram Selvam, Narayanasamy Murugesan, Chamukuttan Snehalatha, Arun Nanditha, Arun Raghavan, Mary Simon, Priscilla Susairaj, Ambady Ramachandran (WDF) Health education on diabetes and other non-communicable diseases imparted to teachers shows a cascading effect. A study from Southern India. Diabetes Res Clin Pract. 2017 Mar;125:20-28
  30. Mentz RJ, Bethel MA, Gustavson S, Thompson VP, Pagidipati NJ, Buse JB, Chan JC, Iqbal N, Maggioni AP, Marso SP, Ohman P, Poulter N, Ramachandran A, Zinman B, Hernandez AF, Holman RR. Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL). Am Heart J. 2017 May;187:1-9.(EXSCEL-2)
  31. Ghosh S, Unnikrishnan AG, Saboo B, Kesavadev J, Aravind SR, Bajaj S, Rajput R, Seshadri K, Verma N, Gupta A,Makkar BM, Saikia M, Kale S, Damodaran S, Dengra A, Eashwar TKM, Maheshwari A, Pendsey S, Phatak SR, Sharma SK, Singh SK, Ramachandran A, Zargar AH, Joshi SR, Sadikot SM. Evidence-based recommendations for insulin intensification strategies after basal insulin in type 2 diabetes. Diabetes Metab Syndr. 2017 Apr 5. pii: S1871-4021(17)30057-7.
  32. Naemi R, Chatzistergos P, Suresh S, Sundar L, Chockalingam N, Ramachandran A. Can plantar soft tissue mechanics enhance prognosis of diabetic foot ulcer? Diabetes Res Clin Pract. 2017 Apr;126:182-191.
  33. Khunti K, Alsifri S, Aronson R, Cigrovski Berković M, Enters-Weijnen C, Forsén T, Galstyan G, Geelhoed-Duijvestijn P,Goldfracht M, Gydesen H, Kapur R, Lalic N, Ludvik B, Moberg E, Pedersen-Bjergaard U, Ramachandran A; HAT Investigator Group. Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes. Diabetes Res Clin Pract. 2017 Aug;130:121-129. doi: 10.1016/j.diabres.2017.05.004. Epub 2017 May 12. (HAT-2)
  34. Weerachai Srivanichakorn, Ian F. Godsland, Hazel Thomson, Shivani Misra, Pochamana Phisalprapa, Phunchai Charatcharoenwitthaya, Pornpoj Pramyothin, Chaiwat Washirasaksiri, Chamukuttan Snehalatha, Ambady Ramachandran, K. George M.M. Alberti, Desmond G. Johnston, Nick S. Oliver. Fasting plasma glucose and variation in cardiometabolic risk factors in people with highrisk HbA1c-defined prediabetes: A cross-sectional multiethnic study DRCP 1 3 4 (2 0 1 7) 1 8 3 –1 9 0
  35. Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP,Marso SP, Öhman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF; EXSCEL Study Group. Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2017 Sep 28;377(13):1228-1239. doi: 10.1056/NEJMoa1612917. Epub 2017 Sep 14. (EXSCEL-3)
  36. Bethel MA, Patel RA, Merrill P, Lokhnygina Y, Buse JB, Mentz RJ, Pagidipati NJ, Chan JC, Gustavson SM, Iqbal N, Maggioni AP, Öhman P, Poulter NR, Ramachandran A, Zinman B, Hernandez AF, Holman RR; EXSCEL Study Group. Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis. Lancet Diabetes Endocrinol. 2018 Feb; 6(2): 105-113.
  37. Snehalatha C, Priscilla S, Nanditha A, Arun R, Satheesh K, Ramachandran A. Metformin in Prevention of Type 2 Diabetes. J Assoc Physicians India. 2018 Mar;66(3):60-3.
  38. Nanditha A,Snehalatha C, Raghavan A, Vinitha R, Satheesh K, Susairaj P, SimonM, Selvam S, Ram J, Kumar APN, Godsland IF, Oliver N, Johnston DG, Ramachandran A. The post-trial analysis of the Indian SMS diabetes prevention study shows persistent beneficial effects of lifestyle intervention. Diabetes Res Clin Pract. 2018 Aug;142:213-221.
  39. Ramachandran A, Kumar R, Nanditha A, Raghavan A, Snehalatha C, Krishnamoorthy S, Joshi P, Tesfaye F. mDiabetes initiative using text messages to improve lifestyle and health-seeking behaviour in India. BMJ Innovations Published Online First: 19 July 2018. doi:10.1136/bmjinnov-2017-000265
  40. Das AK, Unnikrishnan AG, Saboo B, Kumar GV, Sahay R, Kalra S, Bajaj S, Ghosh S, Ramachandran A, Bhattacharya AD, Makkar BM, Bantwal G, Mukherjee JJ, Prasanna Kumar KM, Seshadri K, Dharmalingam M, Baruah M, Chawla R, Venkataraman S, Shah S, Kale S, Joshi SR, Chowdhury S, Bhandari S, Mohan V, Vijay V. Indian Guidance on Cardiovascular and Renal Comorbidity. Management in Type-2 Diabetes mellitus. Journal of the Association of Physicians of India. 2018; 66(supplementary):1-15.
  41. Healy A, Naemi R, Sundar L, Chatzistergos P, Ramachandran A, Chockalingam N. Hallux plantar flexor strength in people with diabetic neuropathy: Validation of a simple clinical test. Diabetes Res Clin Pract. 2018 Oct;144:1-9.
  42. Raghavan A, Nanditha A, Snehalatha C, Vinitha R, Susairaj P, Simon M, Selvam S, Satheesh K, Ram J, Kumar APN, Godsland IF, Oliver N, Johnston DG, Ramachandran A. Incidence of Type 2 Diabetes is Higher among Men with Persistent Impaired Glucose Tolerance than in Transient Impaired Glucose Tolerance – A 5 year Follow up Study. J Assoc Physicians India. 2018 Oct; 66(10):22-26.
  43. Hills AP, Misra A, Gill JMR, Byrne NM, Soares MJ, Ramachandran A, Palaniappan L, Street SJ, Jayawardena R, Khunti K, Arena R. Public health and health systems: implications for the prevention and management of type 2 diabetes in south Asia. Lancet Diabetes Endocrinol. 2018 Dec;6(12):992-1002.
  44. Mentz RJ, Bethel MA, Merrill P, Lokhnygina Y, Buse JB, Chan JC, Felício JS, Goodman SG, Choi J, Gustavson SM, Iqbal N, Lopes RD, Maggioni AP, Öhman P, Pagidipati NJ, Poulter NR, Ramachandran A, Reicher B, Holman RR, Hernandez AF; EXSCEL Study Group. Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial. J Am Heart Assoc. 2018 Oct 2;7(19):e009304.
  45. Pedersen-Bjergaard U, Alsifri S, Aronson R, Berković MC, Galstyan G, Gydesen H, Lekdorf JB, Ludvik B, Moberg E, Ramachandran A, Khunti K. Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real-world studies. Diabetes Obes Metab. 2018 Nov 20.
  46. Nanditha A, Snehalatha C, Satheesh K, Susairaj P, Simon M, Vijaya L, Raghavan A, Vinitha R, Ramachandran A. Secular TRends in DiabEtes in India (STRiDE-I): Change in Prevalence in Ten Years Among Urban and Rural Populations in Tamil Nadu. Diabetes Care. 2019 Jan 18. pii: dc181559. doi: 10.2337/dc18-1559. [Epub ahead of print]
  47. Chatzistergos PE, Healy A, Naemi R, Sundar L, Ramachandran A, Chockalingam N. The relationship between hallux grip force and balance in people with diabetes. Gait Posture. 2019 Feb 23;70:109-115.
  48. Tabesh M, Magliano DJ, Tanamas SK, Surmont F, Bahendeka S, Chiang CE, Elgart JF, Gagliardino JJ, Kalra S, Krishnamoorthy S, Luk A, Maegawa H, Motala AA, Pirie F, Ramachandran A, Tayeb K, Vikulova O, Wong J, Shaw JE. Diabetes management and treatment approaches outside of North America and West Europe in 2006 and 2015. Acta Diabetol. 2019 Aug;56(8):889-897.
  49. Tabesh M, Magliano DJ, Tanamas SK, Surmont F, Bahendeka S, Chiang CE, Elgart JF, Gagliardino JJ, Kalra S, Krishnamoorthy S, Luk A, Maegawa H, Motala AA, Pirie F, Ramachandran A, Tayeb K, Vikulova O, Wong J, Shaw JE. Cardiovascular disease management in people with diabetes outside North America and Western Europe in 2006 and 2015. Diabet Med. 2019 Jul;36(7):878-887.
  50. Jenum AK, Brekke I, Mdala I, Muilwijk M, Ramachandran A, Kjollesdal M, Andersen, Richardsen KR, Douglas A, Cezard G, Sheikh A, Morales CAC, Gill JMR, Sattar N, Bhopal RS, Beune E, Stronks K, Vandvik PO, Valkengoed IGMV. Effects of dietary and physical activity interventions on the risk of type 2 diabetes in South Asians: meta-analysis of individual participant data from randomized controlled trials. Meta-Analysis. Diabetologia. 2019 Aug;62(8):1337-1348.
  51. Ramachandran A, Snehalatha C, Shaw JE, Susairaj P, Simon M, Vijaya L, Satheesh K, Vinitha R, Raghavan A, Nanditha A. Response to comment on Nanditha et al. Secular Trends in Diabetes in India (STRiDE-I): Change in Prevalence in 10 years among Urban and Rural Populatons in Tamil Nadu. Diabetes Care Volume 42, 2019 Aug; 42:476-485. Diabetes Care. 2019 Aug;42(8):e139-e140.
  52. Vinitha R, Nanditha A, Snehalatha C, Satheesh K, Susairaj P, Raghavan A, Ramachandran A. Effectiveness of mobile phone text messaging in improving glycaemic control among persons with newly detected type 2 diabetes. Diabetes Res Clin Pract. 2019 Nov;158.107919.
  53. Nanditha A, Thomson H, Susairaj P, Srivanichakorn W, Oliver N, Godsland IF, Majeed A, Darzi A, Satheesh K, Simon M, Raghavan A, Vinitha R, Snehalatha C, Westgate K, Brage S, Sharp SJ, Wareham NJ, Johnston DG, Ramachandran A. A pragmatic and scalable strategy using mobile technology toromote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trial. Diabetologia. 2020 Jan 9. doi: 10.1007/s00125-019-05061-y. [Epub ahead of print]
  54. Mentz RJ, Bethel MA, Gustavson S, Thompson VP, Pagidipati NJ, Buse JB, Chan JC, Iqbal N, Maggioni AP, Marso SP, Ohman P, Poulter N, Ramachandran A, Zinman B, Hernandez AF, Holman RR. Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL). Am Heart J. 2017 May;187:1-9.(EXSCEL-2
  55. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.Lancet. 2016 Apr 9;387(10027):1513-30
  56. Nanditha A, Snehalatha C, Ram J, Selvam S, Vijaya L, Shetty SA, Arun R, Ramachandran A. Impact of lifestyle intervention in primary prevention of Type 2 diabetes did not differ by baseline age and BMI among Asian-Indian people with impaired glucose tolerance. Diabet Med. 2016 Dec;33(12):1700-1704 (IDPP-1 & 3)
  57. Nanditha A, Snehalatha C, Ram J, Selvam S, Vijaya L, Shetty SA, Arun R, Ramachandran A. Impact of lifestyle intervention in primary prevention of Type 2 diabetes did not differ by baseline age and BMI among Asian-Indian people with impaired glucose tolerance. Diabet Med. 2016 Dec;33(12):1700-1704 (IDPP-1 & 3)
  58. A.Ramachandran (in Acknowledgement section) Sex-specific differences in diabetes prevention: a systematic review and meta-analysis. Diabetologia 2014
  59. A.Ramachandran Know the signs and symptoms of diabetes Editorial, Indian J Med Res 140, November 2014, pp 579-581
  60. The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration Cardiovascular disease, chronic kidney disease, and diabetesmortality burden of cardiometabolic risk factors from 1980to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol August 2014; 2: 634–47
  61. International Diabetes Federation Guideline Development Group.Guidelines Global Guideline for Type 2 Diabetes. Diabetes Research and Clinical Practice 2014; 104:1–52
  62. A.Nanditha, J. Ram, S. Selvam, S. Priscilla, Samith A Shetty, C.Snehalatha, IF.Godsland, DG.Johnston,A.Ramachandran Combining Fasting Plasma Glucose with Gammaglutamyl Transferase Improves the Sensitivity to Predict Incident Diabetes in Asian Indian Men with Impaired Glucose Tolerance. JAPI 2014; 62: 18 – 22. (IDPP3-6)
  63. Ram J, Selvam S, Snehalatha C, Nanditha A, Mary Simon , Samith A Shetty, Godsland IF, Johnston DG, Ramachandran A. Improvement in diet habits, independent of physical activity helps to reduce incident diabetes among prediabetic Asian Indian men. DRCP 2014; 106: 491-495 (IDPP3-5)
  64. Shashank R Joshi, Ambady Ramachandran, Manoj Chadha, Sudip Chatterjee, Rahul Rathod & Sanjay Kalra Acarbose plus metformin fixed-dose combination in the management of type 2 diabetes. Expert Opinion, Pharmacother, Informa Health Care 2014 P.No.1611-20
  65. J. Ram, C. Snehalatha, A. Nanditha, S. Selvam, S. A Shetty, I. F. Godsland, D. G. Johnston and A. Ramachandran Hypertriglyceridaemic waist phenotype as a simple predictive marker of incident diabetes in Asian-Indian men with prediabetes. Diabetic Medicine June2014; 31:1542-1549 (IDPP3-3)
  66. A. Misra, A. Ramchandran, R. Jayawardena, U. Shrivastava and C. Snehalatha Diabetes in South Asians. Review Article. Diabet. Med. 2014; 31: 1153–1162
  67. Ambady Ramachandran, Chamukuttan Snehalatha Prevention of diabetes: How far have we gone? Indian Journal of Endocrinology and Metabolism, May-June 2014 ; Vol 18, Issue 3, 252-253.Editorial
  68. Ramachandran A, Vishal Gupta, Jothydev Kesavadev, Sanjay Kalra Understanding the safety of the new ultra long action basal insulin. JAPI Special Issue 2014; 62: 35-42.
  69. Santhosh Jeyaraj, Ananth Samith Shetty, Champat Raj Roopesh Kumar, Arun Nanditha, Satheesh Krishnamoorthy, Arun Raghavan, K Raghavan, Ambady Ramachandran A case report of liraglutide induced acute pancreatitis. JAPI 2014; 62:64-66.
  70. Ramachandran A, Snehalatha C, Ma RC. Diabetes in South-East Asia: An update for 2013 for the IDF Diabetes Atlas. Diabetes ResClin Pract. 2014; 103:231-237.
  71. Danaei G, Singh GM, Paciorek CJ, Lin JK, Cowan MJ, Finucane MM, Farzadfar F, Stevens GA, Riley LM, Lu Y, Rao M, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group. The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008.Circulation. 2013 Apr 9;127(14):1493-1502.PMID:23481623
  72. Ambady Ramachandran, Chamukuttan Snehalatha, Jagannathan Ram, Sundaram Selvam, Mary Simon, Arun Nanditha, Ananth Samith Shetty,Ian F Godsland, Nish Chaturvedi, Azeem Majeed, Nick Oliver, Christofer Toumazou, K George Alberti, Desmond G Johnston (IDPP3-1) Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial Lancet Diabetes Endocrinol 2013; 1: 191–198
  73. ORIGIN Trial Investigators Characteristics associated with maintenance of mean A1C <6.5% in people with dysglycemia in the ORIGIN trial. Diabetes Care. 2013 Oct;36(10):2915-2922 ( ORIGIN )
  74. Kalra S, Mukherjee JJ, Venkataraman S, Bantwal G, Shaikh S, Saboo B, Das AK, Ramachandran A. Hypoglycemia: The neglected complication. Indian J Endocrinol Metab. 2013 Sep;17(5):819-834.
  75. R. Ambady, C. Snehalatha, A. Samith Shetty and A. Nanditha Primary prevention of Type 2 diabetes in South Asians —challenges and the way forward. Review Article, Diabetic Medicine 2013; 30, 26–34.
  76. Gretchen A Stevens1, Gitanjali M Singh2, Yuan Lu2, Goodarz Danaei3, John K Lin2, Mariel M Finucane2, Adil N Bahalim4, Russell K McIntire4, Hialy R Gutierrez4, Melanie Cowan5, Christopher J Paciorek6, Farshad Farzadfar7, Leanne Riley5, Majid Ezzati8* for the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index) National, regional, and global trends in adult overweight and obesity prevalences. Population Health Metrics 2012,10:22(NCD-RisC)
  77. Stevens RJ, Ali R, Bankhead CR, Bethel MA, Cairns BJ, Camisasca RP, Crowe FL, Farmer AJ, Harrison S, Hirst JA, Home P, Kahn SE, McLellan JH, Perera R, Plüddemann A, Ramachandran A, Roberts NW, Rose PW, Schweizer A,Viberti G, Holman RR. Erratum: Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials. Diabetologia 2012; 55(10):2593-2603.
  78. Ramachandran A, Chamukuttan S, Shetty SA, Arun N, Susairaj P. Obesity in Asia- is it different from the rest of the world Diabetes Metab Res Rev. 2012 Dec;28 Suppl 2:47-51
  79. Beran D, Capewell S, de Courten M, Gale E, Gill G, Husseini A, Keen H, Motala A, O’Flaherty M, Ramachandran A, Swinburn B, Tesfaye S, Unwin N, Wild S, Yudkin JS. The International Diabetes Federation: losing its credibility by partnering with Nestlé? Lancet. 2012 Sep 1;380(9844):805. doi: 10.1016/S0140-6736(12)61449-4
  80. Ramachandran A, Snehalatha C, Samith Shetty A, Nanditha A. (Editorial) Trends in prevalence of diabetes in Asian countries. World Journal of Diabetes 2012; 3(6): 110-117.
  81. The ORIGIN Trial Investigators. n-3 Fatty Acids and cardiovascular outcomes in patients with dysglycemia. NEJM 2012. (ORIGIN)
  82. The ORIGIN Trial Investigators. Basal insulin and cardiovascular and other outcomes in dysglycemia. NEJM 2012. (ORIGIN)
  83. Gagliardino JJ, Aschner P, Baik SH, Chan J, Chantelot JM, Ilkova H, Ramachandran A; IDMPS investigators. Patients’ education, and its impact on care outcomes, resource consumption and working conditions: data from the International Diabetes Management Practices Study (IDMPS). Diabetes Metab. 2012 Apr;38(2):128-34.
  84. Ramachandran A, Snehalatha C, Samith Shetty A, Nanditha A. Predictive value of HbA(1c) for incident diabetes among subjects with impaired glucose tolerance-analysis of the Indian Diabetes Prevention Programmes.Diabet Med. 2012; 29(1):94-98 PMID:21790773. (HbA1C ) (IDPP-1& 2)
  85. Snehalatha C, Nanditha A, Shetty AS, Ramachandran A. Hypertriglyceridaemia either in isolation or in combination with abdominal obesity is strongly associated with atherogenic dyslipidaemia in Asian Indians. DRCP 2011: 94(1): 140 – 145. (HTWP ) (CHS-3)
  86. InterAct Consortium, Langenberg C, Sharp S, Forouhi NG, Franks PW, Schulze MB, Kerrison N, Ekelund U, Barroso I, Panico S, Tormo MJ, Spranger J, Griffin S, van der Schouw YT, Amiano P, Ardanaz E, Arriola L, Balkau B, Barricarte A, Beulens JW, Boeing H, Bueno-de-Mesquita HB, Buijsse B, Chirlaque Lopez MD, Clavel-Chapelon F, Crowe FL, de Lauzon-Guillan B, Deloukas P, Dorronsoro M, Drogan D, Froguel P, Gonzalez C, Grioni S, Groop L, Groves C, Hainaut P, Halkjaer J, Hallmans G, Hansen T, Huerta Castaño JM, Kaaks R, Key TJ, Khaw KT, Koulman A, Mattiello A, Navarro C, Nilsson P, Norat T, Overvad K, Palla L, Palli D, Pedersen O, Peeters PH, Quirós JR, Ramachandran A, Rodriguez-Suarez L, Rolandsson O, Romaguera D, Romieu I, Sacerdote C, Sánchez MJ, Sandbaek A, Slimani N, Sluijs I, Spijkerman AM, Teucher B, Tjonneland A, Tumino R, van der A DL, Verschuren WM, Tuomilehto J, Feskens E, McCarthy M, Riboli E, Wareham NJ. Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia. 2011 Sep;54(9):2272-82. (INTERACT)
  87. The TIDE Trial Investigators Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial. Diabetologia-2011 (TIDE)
  88. Srinivasa V Katikireddi, Joanne R Morling and Raj Bhopal OBESITY AND DIABETES Is there a divergence in time trends in the prevalence of impaired glucose tolerance and diabetes? A systematic review in South Asian populations International Journal of Epidemiology 2011;40:1542–1553
  89. Corder K, Brage S, Wright A, Ramachandran A, Snehalatha C, Yamuna A, Wareham NJ, Ekelund U. Physical activity energy expenditure of adolescents in India. Obesity (Silver Spring). 2010 Nov;18(11):2212-9. Epub 2010 Feb 4.PMID:20134412
  90. Lei Zhang, Qing Qiao, Jaakko Tuomilehto, Edward D. Janus, Tai Hing Lam, Ambady Ramachandran, Viswanathan Mohan, Coen D. A. Stehouwer, Yanhu Dong, Tomoko Nakagami, Altan Onat, and Stefan So¨ derberg, for the DECODE/DECODA Study Group Distinct Ethnic Differences in Lipid Profiles across Glucose Categories. J Clin Endocinol Metab, Apr 2010: 95(4): 1793 – 1801.
  91. Ning F, Qiao Q, Tuomilehto J, Hammar N, Ho SY, Söderberg S, Zimmet PZ, Shaw JE, Nakagami T, Mohan V, Ramachandran A, Lam TH, Andersson SW, Janus ED, Boyko EJ, Fujimoto WY, Pang ZC; DECODA Study Group. Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities? Diabetes Metab Res Rev. 2010 May;26(4):245-53.
  92. List of Publications